PTSM: Pharmaceutical Technology Sourcing and Management
EMA and ECHA sign agreement to share information and work together on risk assessments.
The European Medicines Agency (EMA) and the European Chemicals Agency (ECHA) have entered into an agreement to strengthen the scientific dialogue between the two organizations through sharing expertise and scientific data between their scientific committees, working groups, and panels on matters of common interest.
The working agreement, signed by EMA Executive Director Guido Rasi and ECHA Executive Director Geert Dancet, outlines activities to ensure the best use of available resources and ensure coherence in scientific opinions. The organizations agree to exchange information regarding evaluation and authorization/restriction of chemicals, as relevant for the activities of EMA; share information concerning risk management through classification, labeling, and packaging of substances; cooperate on toxicological assessments by predictive methods and new methodologies; cooperate on biocides; exchange information on environmental risk assessment for both human and veterinary medicinal products and ecotoxicology; and participate in meetings and joint projects.
Source: European Medicines Agency
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.